+287.0%
MRNA vs CF
+58.0%
+229.0%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CF | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.8% | -0.1% | +5.9% | +5.8% |
| 7D | +21.8% | -0.9% | +22.7% | +22.0% |
| 30D | +19.6% | +6.9% | +12.6% | +21.2% |
| 3M | +354.6% | +4.8% | +349.8% | +360.0% |
| 6M | +394.9% | +4.7% | +390.3% | +401.2% |
| YTD | +812.2% | +56.5% | +755.7% | +787.0% |
| 1Y | +996.2% | +48.4% | +947.7% | +968.5% |
| 3Y | +287.0% | +59.1% | +227.8% | +247.5% |
| All | +287.0% | +58.0% | +229.0% | +247.5% |
Cumulative growth
Daily Returns
Daily percentage return beside CF.
Daily Out/Under-Performance
Portfolio return minus CF return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CF return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CF wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling